| Net sales during the quarter marginally went up by 1.85 per cent to Rs 230.5 crore from Rs 226.3 crore. However, total income, decreased to Rs 233.1 crore from Rs 243.8 crore. |
| During the financial year ended December 31, the company has posted 14.7 per cent increase in net profit at Rs 238.5 crore from Rs 207.9 crore in the corresponding previous year. Total income went up by 12.31 per cent to Rs 984.1 crore from Rs 876.2 crore. |
| The Wockhardt board today also recommended a dividend of Rs 5 per equity share for the current financial year. |
| Share prices in Wockhardt today lost 3.27 per cent in a falling Bombay market. The stock closed at Rs 508.95 on the BSE against yesterday's close of Rs 526.15. |
| The group's consolidated results showed an increase of 16 per cent in net profit at Rs 73 crore during the fourth quarter ended December 31, 2005, as compared with Rs 63.1 crore for the corresponding previous quarter. Total income increased to Rs 368.6 crore from Rs 362.3 crore for the correpsonding previous quarter. |
| On a consolidated basis, the company's net profit went up 20 per cent at Rs 257.1 crore for the financial year ended December 31, 2005, as compared with Rs 213.5 crore for the year ended December 31, 2004. |
| Total income increased to Rs 1,430.1 crore for the year from Rs 1267.4 crore. |
| Wockhardt Chairman Habil Khorakiwala said its investments in organisation and people in two critical growth areas were now paying back. |
| "The company's business in the US has grown by more than 50 per cent and the biotechnology business has grown by 54 per cent," he added. |
| Wockhardt has informed the Bombay Stock Exchange that the company's board has approved the raising of funds up to $500 million through issue of equity or equity linked securities. |
Top Section
Explore Business Standard